Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SMSPHARMA.BO and 80,000+ other tickers.
See exactly how SMSPHARMA.BO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SMSPHARMA.BO and 80,000+ other tickers.
SMS Pharmaceuticals Limited, an India-based entity, specializes in the production and commercialization of active pharmaceutical ingredients (APIs) and related intermediates. The company's extensive product portfolio addresses various therapeutic areas, such as anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-viral, anti-coagulant, and anti-retroviral treatments. In addition to its manufacturing activities, the firm engages in contract research. Established in 1987 and headquartered in Hyderabad, India, SMS Pharmaceuticals Limited not only supplies the domestic market but also ships its products globally.
No recent news available.